Tag: AHZ
Admedus agrees to sell CardioCel and VascuCel patch business to LeMaitre Vascular
Admedus (ASX: AHZ) shares have returned to trading after the structural heart company confirmed it would conduct a recapitalisation plan by selling its patch business to a US medical devices firm.
...
CE Mark approval paves way for Admedus to market tissue technology into Europe
Medical technology company Admedus (ASX: AHZ) has moved closer to increasing global sales of its Adapt tissue technology after receiving regulatory approval from European authorities for its CardioCel...
Admedus recruits Cardiva to distribute ADAPT tissue scaffolds in Spain, Portugal
Cardiac medical device technologist Admedus (ASX: AHZ) has refined its worldwide sales strategy, signing up long-time operator Cardiva to distribute its ADAPT bio-scaffolding products in Spain and Por...
Admedus attracts multimillion dollar investment for vaccine research
Medical technology company Admedus (ASX: AHZ) is on the brink of attracting at least $18 million to fund further research into its vaccine program.
Admedus announced that its subsidiary Admedus Vac...
Admedus delivers on shareholder pledge to expand US sales network
Biotech developer Admedus (ASX: AHZ) has signed a purchasing agreement with a major US-based group purchasing organisation (GPO) through its US subsidiary, Admedus Corporation – and delivered on a sha...
Admedus adapts to growing tissue regeneration market in North America
Biotech company Admedus (ASX: AHZ) will soon be introducing its proprietary suite of products to Canadian consumers.
The company received regulatory approval from regulators this week to market Car...
